首页 > 最新文献

ESMO Open最新文献

英文 中文
Uveal melanoma: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up† 葡萄膜黑色素瘤:ESMO-EURACAN临床实践指南:诊断、治疗和随访†
IF 8.3 2区 医学 Q1 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2026-04-02 DOI: 10.1016/j.esmoop.2026.106888
S. Piperno-Neumann , M. Angi , P.A. Ascierto , J.F. Baurain , M.C. Burgmans , N. Cassoux , S.E. Coupland , R. Dendale , A. Fortuna , L. Gastaud , C. Gutierrez-Miguelez , S. Heegaard , M.J. Jager , E. Kapiteijn , U. Keilholz , E. Kilic , M. Marinkovic , A. Moulin , P. Nathan , S.P. Patel , O. Michielin
{"title":"Uveal melanoma: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up†","authors":"S. Piperno-Neumann , M. Angi , P.A. Ascierto , J.F. Baurain , M.C. Burgmans , N. Cassoux , S.E. Coupland , R. Dendale , A. Fortuna , L. Gastaud , C. Gutierrez-Miguelez , S. Heegaard , M.J. Jager , E. Kapiteijn , U. Keilholz , E. Kilic , M. Marinkovic , A. Moulin , P. Nathan , S.P. Patel , O. Michielin","doi":"10.1016/j.esmoop.2026.106888","DOIUrl":"10.1016/j.esmoop.2026.106888","url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"11 4","pages":"Article 106888"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147748179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LBA4 Sacituzumab tirumotecan (sac-TMT) in patients (pts) with previously treated advanced EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC): Final overall survival (OS) analysis from the randomized OptiTROP-Lung03 study 来自OptiTROP-Lung03随机研究的最终总生存期(OS)分析:先前治疗过的晚期egfr突变(EGFRm)非小细胞肺癌(NSCLC)患者(pts)的舒妥珠单抗替鲁替康(sac-TMT)
IF 8.3 2区 医学 Q1 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2026-03-17 DOI: 10.1016/j.esmoop.2026.106960
W.F. Fang , X. Li , Q. Wang , X. Meng , W. Zheng , L. Sun , W. Yao , W. Zhuang , Y. Fan , M. Zhuo , Y. Luo , Z. Zhang , X. Song , R. Yang , J. Yang , Y. Diao , J. Ge , L. Zhang , Y. Yang
{"title":"LBA4 Sacituzumab tirumotecan (sac-TMT) in patients (pts) with previously treated advanced EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC): Final overall survival (OS) analysis from the randomized OptiTROP-Lung03 study","authors":"W.F. Fang , X. Li , Q. Wang , X. Meng , W. Zheng , L. Sun , W. Yao , W. Zhuang , Y. Fan , M. Zhuo , Y. Luo , Z. Zhang , X. Song , R. Yang , J. Yang , Y. Diao , J. Ge , L. Zhang , Y. Yang","doi":"10.1016/j.esmoop.2026.106960","DOIUrl":"10.1016/j.esmoop.2026.106960","url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"11 ","pages":"Article 106960"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147748460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
56P LncRNAs FENDRR, LINC02560, and SOX21-AS1 regulate chemoresistance in advanced gastric cancer 56P LncRNAs FENDRR、LINC02560和SOX21-AS1调控晚期胃癌的化疗耐药
IF 8.3 2区 医学 Q1 ONCOLOGY Pub Date : 2026-04-01 DOI: 10.1016/j.esmoop.2026.106162
I. Riquelme , P. Pérez-Moreno , B. Mora , S. Rivas-Lara , C. Rojas-Fuentes , P.E. Yanez Weber , J.C. Roa , C. Ili , P. Brebi
{"title":"56P LncRNAs FENDRR, LINC02560, and SOX21-AS1 regulate chemoresistance in advanced gastric cancer","authors":"I. Riquelme , P. Pérez-Moreno , B. Mora , S. Rivas-Lara , C. Rojas-Fuentes , P.E. Yanez Weber , J.C. Roa , C. Ili , P. Brebi","doi":"10.1016/j.esmoop.2026.106162","DOIUrl":"10.1016/j.esmoop.2026.106162","url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"11 ","pages":"Article 106162"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147578856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
51eP CTC-targeted allogeneic CAR-T cells as a novel approach to early recurrence in operative PDAC 51eP ctc靶向异体CAR-T细胞作为手术性PDAC早期复发的新途径
IF 8.3 2区 医学 Q1 ONCOLOGY Pub Date : 2026-04-01 DOI: 10.1016/j.esmoop.2026.106156
J. Wierciak , K. Bak , N. Wilczynska-Zawal , K. Rapacz , H. Plutecka , Z. Szwalec , J. Kijowski , M. Sierzega , M. Piejko
{"title":"51eP CTC-targeted allogeneic CAR-T cells as a novel approach to early recurrence in operative PDAC","authors":"J. Wierciak , K. Bak , N. Wilczynska-Zawal , K. Rapacz , H. Plutecka , Z. Szwalec , J. Kijowski , M. Sierzega , M. Piejko","doi":"10.1016/j.esmoop.2026.106156","DOIUrl":"10.1016/j.esmoop.2026.106156","url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"11 ","pages":"Article 106156"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147578835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
53P Epigenetic modulation of TERRA by FTSJ3 supports telomerase-mediated oncogenesis FTSJ3对TERRA的53P表观遗传调控支持端粒酶介导的肿瘤发生
IF 8.3 2区 医学 Q1 ONCOLOGY Pub Date : 2026-04-01 DOI: 10.1016/j.esmoop.2026.106159
N. Jette , J. Price , O. Abuhussein , G. Groot , F. Vizeacoumar , A. Freywald , F. Vizeacoumar
{"title":"53P Epigenetic modulation of TERRA by FTSJ3 supports telomerase-mediated oncogenesis","authors":"N. Jette , J. Price , O. Abuhussein , G. Groot , F. Vizeacoumar , A. Freywald , F. Vizeacoumar","doi":"10.1016/j.esmoop.2026.106159","DOIUrl":"10.1016/j.esmoop.2026.106159","url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"11 ","pages":"Article 106159"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147578837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
126eP Prognostic impact of concomitant genomic alterations in FGFR2-positive cholangiocarcinoma treated with pemigatinib: Molecular analysis of the Italian real-world study pemigatinib治疗fgfr2阳性胆管癌伴发基因组改变对预后的影响:意大利现实世界研究的分子分析
IF 8.3 2区 医学 Q1 ONCOLOGY Pub Date : 2026-04-01 DOI: 10.1016/j.esmoop.2026.106267
C. Liguori , R. Giampieri , A. Parisi , M. Niger , C. Sciortino , S.K. Garattini , A. Pastorino , A. Diana , A. Palloni , L. Foltran , S. Gobba , M. Mandalà , M. Bensi , M. Rimini , R. Balsano , D. Lavacchi , S. Marchetti , A. Alberti , C. Vivaldi , R. Berardi
{"title":"126eP Prognostic impact of concomitant genomic alterations in FGFR2-positive cholangiocarcinoma treated with pemigatinib: Molecular analysis of the Italian real-world study","authors":"C. Liguori , R. Giampieri , A. Parisi , M. Niger , C. Sciortino , S.K. Garattini , A. Pastorino , A. Diana , A. Palloni , L. Foltran , S. Gobba , M. Mandalà , M. Bensi , M. Rimini , R. Balsano , D. Lavacchi , S. Marchetti , A. Alberti , C. Vivaldi , R. Berardi","doi":"10.1016/j.esmoop.2026.106267","DOIUrl":"10.1016/j.esmoop.2026.106267","url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"11 ","pages":"Article 106267"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147578457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3P Clinical significance of achieving no evidence of disease in HER2-positive metastatic breast cancer: A multicenter study by Turkish Oncology Group (TOG) her2阳性转移性乳腺癌无疾病证据的3P临床意义:土耳其肿瘤组(TOG)的一项多中心研究
IF 8.3 2区 医学 Q1 ONCOLOGY Pub Date : 2026-04-01 DOI: 10.1016/j.esmoop.2026.106106
B. Dursun , S. Yaslikaya , S. Sekmek , T. Önder , H.C. Yildirim , O. Acar , N. Sever , S. Gokcek , S. Ön , F. Aslan , G.S.Y. Keskin , Z. Sucuoglu Isleyen , G. Savas , M.E. Kalender , O. Bal , U.Y. Arslan , M. Sahbazlar , B. Cakar , H.M. Türk , H. Akbulut
{"title":"3P Clinical significance of achieving no evidence of disease in HER2-positive metastatic breast cancer: A multicenter study by Turkish Oncology Group (TOG)","authors":"B. Dursun , S. Yaslikaya , S. Sekmek , T. Önder , H.C. Yildirim , O. Acar , N. Sever , S. Gokcek , S. Ön , F. Aslan , G.S.Y. Keskin , Z. Sucuoglu Isleyen , G. Savas , M.E. Kalender , O. Bal , U.Y. Arslan , M. Sahbazlar , B. Cakar , H.M. Türk , H. Akbulut","doi":"10.1016/j.esmoop.2026.106106","DOIUrl":"10.1016/j.esmoop.2026.106106","url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"11 ","pages":"Article 106106"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147578812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
18P Targeting MET-expressing NSCLC with a VNAR-based theranostic agent 18P靶向表达met的NSCLC与基于vnar的治疗剂
IF 8.3 2区 医学 Q1 ONCOLOGY Pub Date : 2026-04-01 DOI: 10.1016/j.esmoop.2026.106121
J. West , R. Minne , K. Nickel , G. Gunaratne , R. Hernandez , A. Baschnagel , R. Kimple , A. Lebeau
{"title":"18P Targeting MET-expressing NSCLC with a VNAR-based theranostic agent","authors":"J. West , R. Minne , K. Nickel , G. Gunaratne , R. Hernandez , A. Baschnagel , R. Kimple , A. Lebeau","doi":"10.1016/j.esmoop.2026.106121","DOIUrl":"10.1016/j.esmoop.2026.106121","url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"11 ","pages":"Article 106121"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147578819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
36P Reclassification of 9,534 germline VUS in ATM and PALB2 via alphamissense and structural modeling: Unveiling predicted targets for precision oncology 通过字母错义和结构建模对9534个ATM和PALB2种系VUS进行重分类:揭示精准肿瘤学预测靶点
IF 8.3 2区 医学 Q1 ONCOLOGY Pub Date : 2026-04-01 DOI: 10.1016/j.esmoop.2026.106140
A. Kuskucu , O.A. Cavus
{"title":"36P Reclassification of 9,534 germline VUS in ATM and PALB2 via alphamissense and structural modeling: Unveiling predicted targets for precision oncology","authors":"A. Kuskucu , O.A. Cavus","doi":"10.1016/j.esmoop.2026.106140","DOIUrl":"10.1016/j.esmoop.2026.106140","url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"11 ","pages":"Article 106140"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147578827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
94P Autophagy supports the drug-tolerant persister state during targeted therapy in colorectal cancer 94P自噬支持结直肠癌靶向治疗过程中的耐药持续状态
IF 8.3 2区 医学 Q1 ONCOLOGY Pub Date : 2026-04-01 DOI: 10.1016/j.esmoop.2026.106236
T. Li, M. Putz, A. Maghnouj, R. Hafez, S. Hahn
{"title":"94P Autophagy supports the drug-tolerant persister state during targeted therapy in colorectal cancer","authors":"T. Li, M. Putz, A. Maghnouj, R. Hafez, S. Hahn","doi":"10.1016/j.esmoop.2026.106236","DOIUrl":"10.1016/j.esmoop.2026.106236","url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"11 ","pages":"Article 106236"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147578436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ESMO Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1